CGEN

Value Q4, 25 TTM Total revenue — — Gross profit — — Operating expenses — — Selling/general/admin expenses — — Research & development — — Operating income — — Non-Operating Income, Total — — Interest expense, net of interest capitalized — — Non-Operating Income, excl. Interest Expenses — — Unusual income/expense — — Pretax income 35.4 M -17.73 M Equity in earnings — — Taxes 209 K — Non-controlling/minority interest — — After tax other income/expense — — Net income before discontinued operations 35.19 M -17.94 M Discontinued operations — — Net income 35.19 M -17.94 M Dilution adjustment — — Preferred dividends — — Diluted net income available to common stockholders 35.19 M -17.94 M Basic earnings per share (Basic EPS) — — Diluted earnings per share (Diluted EPS) 0.38 -0.23 Average basic shares outstanding 93.43 M — Diluted shares outstanding 93.82 M — EBITDA — — EBIT — — Cost of revenue — — Other cost of goods sold — — Depreciation & amortization (cash flow) — —